Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sop… Read more
Achieve Life Sciences Inc (ACHV) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.337x
Based on the latest financial reports, Achieve Life Sciences Inc (ACHV) has a cash flow conversion efficiency ratio of -0.337x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-11.33 Million) by net assets ($33.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Achieve Life Sciences Inc - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how Achieve Life Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Achieve Life Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Achieve Life Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
en-japan inc.
PINK:ENJPY
|
0.035x |
|
Baiyang Aquatic Group Inc
SHE:002696
|
0.003x |
|
Shanghai Kaichuang Marine International Co Ltd
SHG:600097
|
-0.022x |
|
Anima Holding SpA
F:124
|
0.093x |
|
Zion Oil & Gas Inc
OTCQB:ZNOG
|
-0.035x |
|
CUSTODIAN PROP.INC.LS-01
F:IT3
|
N/A |
|
Know IT AB
ST:KNOW
|
0.078x |
|
Parpro Corp
TW:4916
|
0.003x |
Annual Cash Flow Conversion Efficiency for Achieve Life Sciences Inc (1994–2024)
The table below shows the annual cash flow conversion efficiency of Achieve Life Sciences Inc from 1994 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $20.90 Million | $-29.77 Million | -1.424x | -108.43% |
| 2023-12-31 | $-1.45 Million | $-24.48 Million | 16.905x | +473.62% |
| 2022-12-31 | $8.30 Million | $-37.57 Million | -4.525x | -330.99% |
| 2021-12-31 | $28.04 Million | $-29.44 Million | -1.050x | -190.52% |
| 2020-12-31 | $37.29 Million | $-13.47 Million | -0.361x | +57.13% |
| 2019-12-31 | $18.05 Million | $-15.22 Million | -0.843x | -25.40% |
| 2018-12-31 | $15.80 Million | $-10.62 Million | -0.672x | +41.84% |
| 2017-12-31 | $7.88 Million | $-9.11 Million | -1.156x | +26.15% |
| 2016-12-31 | $18.97 Million | $-29.68 Million | -1.565x | -543.84% |
| 2015-12-31 | $37.44 Million | $-9.10 Million | -0.243x | +52.17% |
| 2014-12-31 | $34.06 Million | $-17.31 Million | -0.508x | +47.37% |
| 2013-12-31 | $37.21 Million | $-35.93 Million | -0.965x | -46.97% |
| 2012-12-31 | $66.21 Million | $-43.49 Million | -0.657x | -0.15% |
| 2011-12-31 | $30.89 Million | $-20.26 Million | -0.656x | -7.84% |
| 2010-12-31 | $44.12 Million | $-26.84 Million | -0.608x | -140.04% |
| 2009-12-31 | $22.96 Million | $34.88 Million | 1.519x | +232.16% |
| 2008-12-31 | $10.71 Million | $-12.31 Million | -1.149x | -57.15% |
| 2007-12-31 | $31.90 Million | $-23.34 Million | -0.731x | -59.96% |
| 2006-12-31 | $43.04 Million | $-19.68 Million | -0.457x | -92.89% |
| 2005-12-31 | $35.26 Million | $-8.36 Million | -0.237x | +69.07% |
| 2004-12-31 | $19.08 Million | $-14.62 Million | -0.766x | -49.34% |
| 2003-12-31 | $19.31 Million | $-9.91 Million | -0.513x | +22.41% |
| 2002-12-31 | $15.72 Million | $-10.40 Million | -0.661x | -876.37% |
| 2001-12-31 | $14.67 Million | $1.25 Million | 0.085x | +118.24% |
| 2000-12-31 | $8.51 Million | $-3.97 Million | -0.467x | -4570.19% |
| 1999-12-31 | $10.00 Million | $-100.00K | -0.010x | +99.27% |
| 1998-12-31 | $7.50 Million | $-10.30 Million | -1.373x | -1914.76% |
| 1997-12-31 | $18.50 Million | $1.40 Million | 0.076x | -63.68% |
| 1996-12-31 | $16.80 Million | $3.50 Million | 0.208x | +129.11% |
| 1995-12-31 | $10.90 Million | $-7.80 Million | -0.716x | -284.01% |
| 1994-12-31 | $-9.00 Million | $-3.50 Million | 0.389x | -- |